−0.13 HKD
−40.09 M HKD
625.00 M HKD
298.71 M
About FUSEN PHARMACEUTICAL CO LTD
Fusen Pharmaceutical Co., Ltd. engages in the manufacture of pharmaceuticals and medical devices. Its products include carbamazepine tablet, bismuth sub carbonate tablet, injection, dextran 40 glucose injection, azithromycin & glucose injection, cimetidine tablet, vitamin U, aluminum hydroxide and magnesium tablet, yuanhu zhitong oral solution, piracetam injection and medical equipment. The company was founded on January 18, 2013 and is headquartered in Xichuan, China.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 1652 is 0.81 HKD — it hasn't changed in the past 24 hours. Watch FUSEN PHARMACEUTICAL CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange FUSEN PHARMACEUTICAL CO LTD stocks are traded under the ticker 1652.
1652 stock has fallen by −7.95% compared to the previous week, the month change is a −8.99% fall, over the last year FUSEN PHARMACEUTICAL CO LTD has showed a −38.64% decrease.
1652 reached its all-time high on Feb 3, 2020 with the price of 20.00 HKD, and its all-time low was 0.75 HKD and was reached on Oct 14, 2024. View more price dynamics on 1652 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
1652 stock is 8.00% volatile and has beta coefficient of 0.25. Track FUSEN PHARMACEUTICAL CO LTD stock price on the chart and check out the list of the most volatile stocks — is FUSEN PHARMACEUTICAL CO LTD there?
Today FUSEN PHARMACEUTICAL CO LTD has the market capitalization of 590.20 M, it has decreased by −11.96% over the last week.
Yes, you can track FUSEN PHARMACEUTICAL CO LTD financials in yearly and quarterly reports right on TradingView.
1652 net income for the last half-year is −40.03 M HKD, while the previous report showed −56.97 M HKD of net income which accounts for 29.73% change. Track more FUSEN PHARMACEUTICAL CO LTD financial stats to get the full picture.
As of Dec 22, 2024, the company has 1.15 K employees. See our rating of the largest employees — is FUSEN PHARMACEUTICAL CO LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. FUSEN PHARMACEUTICAL CO LTD EBITDA is −21.90 M HKD, and current EBITDA margin is 9.84%. See more stats in FUSEN PHARMACEUTICAL CO LTD financial statements.
Like other stocks, 1652 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade FUSEN PHARMACEUTICAL CO LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So FUSEN PHARMACEUTICAL CO LTD technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating FUSEN PHARMACEUTICAL CO LTD stock shows the sell signal. See more of FUSEN PHARMACEUTICAL CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.